FDA guideline on BE, draft August 2021 [BE/BA News]

posted by Achievwin – US, 2021-08-23 21:35 (356 d 11:05 ago) – Posting: # 22534
Views: 1,882

» FDA updated the canonical BE guideline for ANDAs. Draft. :-)

Comments period is open till October 22, 2021, Therefore any issues bothering/benefit ANDA folks can be sent to FDA as comments for consideration.

FDA decided to split BA/BE guidance into two guidance 1) for ANDA filings and 2) for IND/NDAs

More elaborate explanations of each aspect.

Complete thread:

UA Flag
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 9 (0 registered, 9 guests [including 2 identified bots]).
Forum time: Monday 08:41 CEST (Europe/Vienna)

Science… never solves a problem
without creating ten more.    George Bernard Shaw

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz